Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

3 May 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23644819
DOI: 10.1007/s00401-013-1121-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson diseasePMID 23644819Read ↗

Cerebrospinal fluid biomarker for Parkinson's disease: An overviewSemantic proximity Read ↗

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomicsSemantic proximity Read ↗

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.Semantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approachSemantic proximity Read ↗

Parkinson's disease--the continuing search for biomarkers.Semantic proximity Read ↗

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian DisordersSemantic proximity Read ↗

Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical featuresSemantic proximity Read ↗

Biomarkers of Parkinson’s disease: 20 years laterSemantic proximity Read ↗

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease ProgressionSemantic proximity Read ↗

Cerebrospinal fluid and plasma clusterin levels in Parkinson's diseaseSemantic proximity Read ↗

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.